Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

SUBJECTS number

Some design options are shown in Tables 20.4 through 20.8, while the implications for going with one or other in terms of subject numbers, number of clinic visits, highest first dose given to a subject, biggest increment in dose, and time to complete the study are given in Table 20.9. [Pg.793]

Interim reviews of the data are an essential requirement to minimise risk during dose-escalation studies. After each study day, or certainly after a predefined number of volim-teers have received the next dose increment, the investigator, nurses, study physician and preferably one or two other experienced physicians who are not intimately involved with the study should meet to review the data. When the study is being conducted in a CRO, a sponsor company physician and a limited number of other personnel should participate by tele- or video-conference if not in person. A decision to stop, modify or continue dose escalation should be made jointly between the Principal Investigator at the CRO and the sponsor s physician. Such reviews should be conducted with maintenance of the double-blind and steps should be taken to avoid inadvertent unblinding, such as by coding of subject numbers. The data that should be reviewed are listed in Box 4.12. [Pg.169]

Each page of the CRF should include investigator identification, study subject number, protocol number, subject initials, and visit and/or study day. All pages are numbered as v of y pages with the version and date of CRFs in a footer. Each appropriate section requires the signature from the investigator and a final sign-off. [Pg.247]

Some of the earliest studies of psychotropic medications in preschool-age children involved neuroleptics. In autism, antipsychotics are the most frequently used psychoactive agents for the reduction of stereotypies, temper tantrums, aggressiveness against self or others, and hyperactivity (Campbell et al., 1999). There are seven studies with preschoolers with a total subject number of 59. Each of these seven studies involved medication trials with preschool children diagnosed with autism or childhood schizophrenia (Table 49.5). Only one study was a randomized, double-blind, pla-... [Pg.662]

Meanwhile, we should avoid terms like "the LSD state." we should not believe that the statement, "x took LSD" (or any powerful psychedelic drug), tells us much about what happened to x s consciousness, indeed, a statement like "subjects were administered 1.25 micrograms of LSD per kilogram of body weight," commonly found in the experimental literature, is especially misleading because it seems so precise. It must be replaced by statements like "subject number 2 was administered such and such as dose of LSD, which then produced a d-ASC of type X, while subject number 3 did not enter a d-ASC with the same dose of LSD."... [Pg.148]

CGM system Number of subjects Number of points Mean absolute relative difference Bias... [Pg.148]

In addition, subject number 22 contained 9320 mg per cent pesticide in the vomitus. [Pg.271]

In addition, 8.12, 3.25, 20.00 mg per cent was found in the vomitus of subject numbers 2,9, and 20 respectively. Also, subject number 2 showed 6.38 mg per cent pesticide in the stomach contents. [Pg.272]

Read the sentence aloud in your mind and see if you can hear a mistake. What answer did you come up with If you choose c, you are right. The subject (number) is singular, so the verb should be also. This is an example of one of the most common questions on the SAT. [Pg.17]

Subject number Weight after placebo (kg) Weight after active (kg) Change in weight (active-placebo) (kg)... [Pg.134]

Subject Number/ Adverse Events, Elevated CRP Elevated... [Pg.323]

For patients with hepatic impairment, the subject number is followed by the Pugh score in brackets. [Pg.699]

Of the many salivary and plaque factors potentially influencing calculus and caries, only oral calcium and inorganic phosphate levels appear to make a significant independent contribution, in the studies reviewed in section 1.5. The lack of discrimination between caries- or calculus-susceptible groups and corresponding non-susceptible groups in many studies of potentially relevant factors, is likely to be because subject numbers were too small. [Pg.23]


See other pages where SUBJECTS number is mentioned: [Pg.626]    [Pg.128]    [Pg.132]    [Pg.138]    [Pg.148]    [Pg.148]    [Pg.163]    [Pg.163]    [Pg.170]    [Pg.170]    [Pg.185]    [Pg.750]    [Pg.906]    [Pg.209]    [Pg.237]    [Pg.221]    [Pg.281]    [Pg.659]    [Pg.63]    [Pg.164]    [Pg.317]    [Pg.249]    [Pg.74]    [Pg.2807]    [Pg.246]    [Pg.282]    [Pg.240]    [Pg.240]    [Pg.240]    [Pg.887]   
See also in sourсe #XX -- [ Pg.944 , Pg.950 ]




SEARCH



Charge number Subject

Compound Name, Code Number and Subject , Volume

Molecular equivalence numbers Subject

Number of Subjects Examined

Number of subjects

Number of the subject

Placebo subject numbers

Placebo-controlled studies subject numbers

Reduction of directly observed cycle numbers in subjects

Reynolds number Subject

SUBJECTS triangular numbers

Schmidt number Subject

Substance Search with Registry Number and Subject Terms

Transference number 430 Subject

Turnover number 430 Subject

© 2024 chempedia.info